ATE119161T1 - Diazabicycloalkan-derivate. - Google Patents

Diazabicycloalkan-derivate.

Info

Publication number
ATE119161T1
ATE119161T1 AT90901005T AT90901005T ATE119161T1 AT E119161 T1 ATE119161 T1 AT E119161T1 AT 90901005 T AT90901005 T AT 90901005T AT 90901005 T AT90901005 T AT 90901005T AT E119161 T1 ATE119161 T1 AT E119161T1
Authority
AT
Austria
Prior art keywords
derivatives
diazabicycloalkan
group
activating
sulfur
Prior art date
Application number
AT90901005T
Other languages
English (en)
Inventor
Etsuo Hasegawa
Akihiro Kawaguchi
Makoto Kajitani
Mitsugi Yasumoto
Nobuo Kasahara
Junji Yamamoto
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE119161T1 publication Critical patent/ATE119161T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT90901005T 1988-12-28 1989-12-27 Diazabicycloalkan-derivate. ATE119161T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63335159A JP2585086B2 (ja) 1988-12-28 1988-12-28 ジアザビシクロアルカン誘導体

Publications (1)

Publication Number Publication Date
ATE119161T1 true ATE119161T1 (de) 1995-03-15

Family

ID=18285428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90901005T ATE119161T1 (de) 1988-12-28 1989-12-27 Diazabicycloalkan-derivate.

Country Status (9)

Country Link
US (1) US5068235A (de)
EP (1) EP0406439B1 (de)
JP (1) JP2585086B2 (de)
KR (1) KR920008823B1 (de)
AT (1) ATE119161T1 (de)
AU (1) AU626972B2 (de)
DE (1) DE68921470T2 (de)
ES (1) ES2071814T3 (de)
WO (1) WO1990007509A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635652B1 (en) * 1999-07-30 2003-10-21 Zenyaku Kogyo Kabushiki Kaisha Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient
WO2002096911A1 (en) * 2001-06-01 2002-12-05 Neurosearch A/S Novel heteroaryl-diazabicyclo-alkanes as cns-modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives

Also Published As

Publication number Publication date
EP0406439A4 (en) 1991-12-11
KR910700252A (ko) 1991-03-14
JPH02178282A (ja) 1990-07-11
EP0406439B1 (de) 1995-03-01
JP2585086B2 (ja) 1997-02-26
DE68921470D1 (de) 1995-04-06
ES2071814T3 (es) 1995-07-01
US5068235A (en) 1991-11-26
DE68921470T2 (de) 1995-08-03
AU4830890A (en) 1990-08-01
WO1990007509A1 (fr) 1990-07-12
AU626972B2 (en) 1992-08-13
EP0406439A1 (de) 1991-01-09
KR920008823B1 (ko) 1992-10-09

Similar Documents

Publication Publication Date Title
ATE116306T1 (de) Hypoglykämische oxazolidindion-derivate.
DE69221794D1 (de) 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
DK0651754T3 (da) K-252a-derivater
DK670389A (da) Benzyliden-azolylmethylcycloalkan- eller -alken-derivater og deres anvendelse til plantebeskyttelse
DE69127437D1 (de) Stickoxide zur gewichtsreduktion
ATE78659T1 (de) Quaternaere ammonium- und benzothiazolkonservierungszusammensetzung.
ATE159718T1 (de) Oxoindolderivate
PT596809E (pt) Processo de preparacao de beta-dicetonas
NO971219L (no) Behandling og profylakse av pankreatitt
DE68921470D1 (de) Diazabicycloalkan-derivate.
DE69114778D1 (de) Bicyclolactamderivat.
PL284026A1 (en) Method of obtaining novel derivatives of benzoxazolone
ATE148116T1 (de) Piperidin-derivate mit antihistaminischer und antileukomenischer wirkung
DK277787D0 (da) Azaphospholener og deres anvendelse
ATE44144T1 (de) 6h-dibenzo(b,e)(1,4)oxathiepin-verbindungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee